[
    "{\"step_by_step_thinking\": \"OXLUMO is the brand name for lumasiran. According to Document [0], lumasiran is used in the treatment of primary hyperoxaluria type 1. This is further confirmed by Document [1], which states that the FDA approved the use of lumasiran for type 1 primary hyperoxaluria in November 2020. Therefore, OXLUMO (lumasiran) is indeed used for the treatment of primary hyperoxaluria.\", \"answer_choice\": \"A\"}"
]